The aim of this study was to investigate whether insulin sensitivity, beta‐cell function or glycaemic control at diagnosis predict initiation of second‐line treatment in newly diagnosed type 2 diabetes. Click to show full abstract
The aim of this study was to investigate whether insulin sensitivity, beta‐cell function or glycaemic control at diagnosis predict initiation of second‐line treatment in newly diagnosed type 2 diabetes.
               
Click one of the above tabs to view related content.